Interferon- (IFN ) Daily Dose Versus IFN Plus Ribavirin for Treatment-Naive Chronic Hepatitis C Patients Infected by Genotype 1b

Author： Scotto G.

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.17, Iss.4, 2003-01, pp. : 281-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon- Alone versus Interferon- plus Ribavirin in Patients with Chronic Hepatitis C Not Responding to Previous Interferon- Treatment

By Tripi S.

BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 299-304

Adis International

Access to resources Recommend Favorite

Interleukin-2 Plus Ribavirin Versus Interferon- -2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon- -2b Treatment

By Mariano Malaguarnera

BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 407-413

Adis International

Access to resources Recommend Favorite

Good Safety Profile and Efficacy of Leucocyte Interferon- in Combination with Oral Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C: A Multicentre, Randomised, Controlled Study

By Barbaro G.

BioDrugs, Vol. 17, Iss. 6, 2003-01 ,pp. : 433-439

Adis International

Access to resources Recommend Favorite

Interferon Alfacon-1: A Novel Interferon for the Treatment of Chronic Hepatitis C

By Alberti A.

BioDrugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 343-357

Adis International

Access to resources Recommend Favorite

Combination Therapy with Interferon- and Ribavirin for Hepatitis C: Practical Treatment Issues

By Collier J. Chapman R.

BioDrugs, Vol. 15, Iss. 4, 2001-04 ,pp. : 225-238

Adis International

Access to resources Recommend Favorite